Teva Pharmaceutical Industries Limited (TEVA) Stock Overview
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules,…
Source: Yahoo Finance
Sector & Industry
Teva Pharmaceutical Industries Limited operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NYSE exchange.
Teva Pharmaceutical Industries Limited at a Glance
| Company | Teva Pharmaceutical Industries Limited |
| Ticker | TEVA |
| Exchange | NYSE |
| Currency | USD |
| Price | $36.36 |
| Market cap | $42.37B |
| P/E ratio (trailing) | 60.60 |
| EPS (trailing) | $0.60 |
| 52-week high | $38.37 |
| 52-week low | $18.21 |
| Dividend yield | — |
| Ex-dividend date (last paid) | 27 Nov 2017 |
| Beta | 0.87 |
| Return on equity (ROE) | 9.69% |
| Debt-to-equity | 217.79% |
| Average volume | 5.54M |
| Shares outstanding | 1.17B |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 31,173 |
| Country | Israel |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Teva Pharmaceutical Industries Limited's current P/E ratio?
- Teva Pharmaceutical Industries Limited (TEVA) has a trailing P/E ratio of 60.60 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Teva Pharmaceutical Industries Limited's market capitalisation?
- Teva Pharmaceutical Industries Limited's market cap is $42.37B based on our latest snapshot. See how it ranks by market cap →
- What is TEVA's 52-week range?
- Over the past 52 weeks, TEVA has traded between $18.21 and $38.37. What does the 52-week range mean? →
- How volatile is Teva Pharmaceutical Industries Limited compared to the market?
- Teva Pharmaceutical Industries Limited has a beta of 0.87, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Teva Pharmaceutical Industries Limited pay a dividend?
- Teva Pharmaceutical Industries Limited does not currently pay a dividend according to our latest data.
- What exchange is TEVA listed on?
- TEVA is listed on the NYSE. Browse all NYSE-listed stocks →
- What sector is Teva Pharmaceutical Industries Limited in?
- Teva Pharmaceutical Industries Limited is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →